Skip to content

Effects of Exercise Mode on Cardiac Fat and Function

Effects of Exercise Mode on Cardiac Fat and Function

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03297333
Enrollment
18
Registered
2017-09-29
Start date
2017-10-01
Completion date
2020-03-16
Last updated
2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Exercise, Cardiac Fat, Cardiac Magnetic Resonance, Vascular Health

Brief summary

The overall goal of this project is to study the effects of exercise energy expenditure matched vigorous dynamic resistance training and aerobic training on cardiac fat, and its relationship to cardiac function and geometry using cardiac Magnetic Resonance Imaging.

Detailed description

Exercise-induced weight-loss is one of the most common strategies for reducing excess fat in overweight and obese individuals. Although vigorous intensity may be more favorable promoting positive cardiac adaptations compared to low-moderate intensity, evidence of the positive effects of different exercise modes needs to be explored to allow for realistic comparisons with other strategies. Research using cardiac Magnetic Resonance Imaging that compares the effects of different modes of exercise - matched by exercise energy expenditure - on epicardial adipose tissue and paracardial adipose tissue, and how these interventions modify cardiac function and geometry have not been previously explored in obesity.

Interventions

OTHERResistance training

The resistance training group

The aerobic interval training group

Sponsors

Southern Illinois University Edwardsville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Sedentary * Caucasian * BMI \>30 kg/m2 and \< 39.9 kg/m2

Exclusion criteria

* Known cardiovascular, metabolic, pulmonary disease or conditions * Muscular-skeletal injuries * Taking medications that affect endocrine or cardiovascular function * Hypertension * Being engaged in low intensity strength training more than two times per week or moderate-high intensity of any type of frequency * Being pregnant * Cigarette smoking * Having non-removable pieces or devices incompatible with DXA and CMR assessment.

Design outcomes

Primary

MeasureTime frameDescription
Changes in Epicardial adipose tissue (EAT)2 assessment points: at baseline and week 4EAT will be measured using cardiac Magnetic Resonance
Changes in Vascular Health2 assessment points: at baseline and week 4Atrial stiffness will be measured using a pulse wave analysis

Secondary

MeasureTime frameDescription
Changes in Paracardial adipose tissue (PAT)2 assessment points: at baseline and week 4PAT will be measured using cardiac Magnetic Resonance
Changes in Body Composition2 assessment points: at baseline and week 4Body composition will be measured using dual-energy x-ray absorptiometry
Changes in Cardiorespiratory Function2 assessment points: at baseline and week 4Cardiorespiratory Function will be measured on a treadmill with a metabolic cart
Changes in Muscular Strength2 assessment points: at baseline and week 4Muscular Strength will be assessed by 1 repetition maximum (1RM) test

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026